Louis J. DeGennaro

Director/Board Member at BioTheryX, Inc.

Commercial Services

Health Technology

Profile

Louis J.
DeGennaro is currently a Director at BioTheryX, Inc. He was previously the President & Chief Executive Officer at The Leukemia & Lymphoma Society, Inc. from 2014 to 2023.

Louis J. DeGennaro active positions

Companies	Position	Start
BioTheryX, Inc. BioTheryX, Inc. Pharmaceuticals: MajorHealth Technology BioTheryX, Inc. pengages in the development of clinical drugs. It focuses on the restoration of protein homeostasis, including protein degradation and modulation, and multi-kinase inhibition. The company was founded by David I. Stirling and Lawrence Zaslow in 2007 and is headquartered in Chappaqua, NY.	Director/Board Member	-

All active positions of Louis J. DeGennaro

Former positions of Louis J. DeGennaro

Companies	Position	End
The Leukemia & Lymphoma Society, Inc. The Leukemia & Lymphoma Society, Inc. Miscellaneous Commercial ServicesCommercial Services The Leukemia & Lymphoma Society, Inc. operates as the world's largest voluntary health organization dedicated to funding blood cancer research, education and patient services. The firm provides treatment for , lymphoma, Hodgkin's disease and myeloma, and improve the quality of life of patients and their families. It identifies and funds the most promising blood cancer research projects and forges partnerships with academic institutions, biotechnology and pharmaceutical companies to accelerate the development of new therapies. The company is headquartered in Rye Brook, NY.	Chief Executive Officer	01/05/2023

See the detail of Louis J. DeGennaro's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Louis J. DeGennaro's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	2
The Leukemia & Lymphoma Society, Inc. The Leukemia & Lymphoma Society, Inc. Miscellaneous Commercial ServicesCommercial Services The Leukemia & Lymphoma Society, Inc. operates as the world's largest voluntary health organization dedicated to funding blood cancer research, education and patient services. The firm provides treatment for , lymphoma, Hodgkin's disease and myeloma, and improve the quality of life of patients and their families. It identifies and funds the most promising blood cancer research projects and forges partnerships with academic institutions, biotechnology and pharmaceutical companies to accelerate the development of new therapies. The company is headquartered in Rye Brook, NY.	Commercial Services
BioTheryX, Inc. BioTheryX, Inc. Pharmaceuticals: MajorHealth Technology BioTheryX, Inc. pengages in the development of clinical drugs. It focuses on the restoration of protein homeostasis, including protein degradation and modulation, and multi-kinase inhibition. The company was founded by David I. Stirling and Lawrence Zaslow in 2007 and is headquartered in Chappaqua, NY.	Health Technology